All In Biotech

Drug Trial Radar · NCT05892718

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

A Phase 1, Open-label, Multi-center, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HCB101 in Subjects With Advanced Solid Tumors or Relapsed and Refractory Non-Hodgkin Lymphoma

Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Oct 2, 2023

Primary completion

May 30, 2027

Study completion Nov 15, 2029

Sponsor

Lead sponsor
FBD Biologics LimitedIndustry
Sponsor type
Industry
First posted
Jun 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what side effects (unwanted effects) may occur in subjects aged 18 years old and above.

Conditions

  • Advanced Solid Tumor
  • Refractory Non-Hodgkin Lymphoma

Interventions

  • HCB101Drug

    HCB101 administered via. intravenous (IV) infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number/incidence and percentage of subjects with adverse events, including ADA.Time frame: 12 months
  2. Number of subjects with MTD of HCB101Time frame: 12 months

Locations

8 sites in 3 countries. Site status is shown where the registry gives one.

  • Hematology-Oncology Associates of the Treasure Coast

    Port Saint Lucie, Florida · Recruiting

  • Carolina BioOncology

    Huntersville, North Carolina · Recruiting

  • Greenville Hospital System University Medical Center (ITOR)

    Greenville, South Carolina · Recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Hangzhou First People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Taipei Medical University - Shuang Ho Hospital, Ministry of Health and Welfare

    New Taipei City, Taiwan · Recruiting

  • National Taiwan University Hospital

    Taipei, Taiwan · Recruiting

  • Taipei Veterans General Hospital

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.